Format

Send to

Choose Destination
Ann Allergy Asthma Immunol. 2018 Apr;120(4):429-430. doi: 10.1016/j.anai.2018.01.026. Epub 2018 Feb 2.

Evaluation of the safety of a protocol for switching venom immunotherapy products.

Author information

1
Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy. Electronic address: erminia.ridolo@unipr.it.
2
Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy.
3
Allergy & Respiratory Diseases, Ospedale Policlinico, San Martino, Genoa.
4
Allergy Unit, Sant'Anna Hospitalm ASST Lariana, Como, Italy.
5
Cardiac/Pulmonary Rehabilitation, ASST Pini/CTO, Milan, Italy.
PMID:
29409970
DOI:
10.1016/j.anai.2018.01.026
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center